Filing Details
- Accession Number:
- 0001683168-24-002940
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-02 20:20:51
- Reporting Period:
- 2024-04-30
- Accepted Time:
- 2024-05-02 20:20:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
704562 | Avid Bioservices Inc. | CDMO | Pharmaceutical Preparations (2834) | 953698422 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1974519 | R. Matthew Kwietniak | 14191 Myford Road Tustin CA 92780 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.001 Par Value | Disposition | 2024-04-30 | 1,233 | $7.40 | 21,797 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represents the shares sold by the reporting person pursuant to a contractual election to satisfy tax withholding obligations in connection with the release of restricted stock units ("RSUs") which vested on April 9, 2024 and April 11, 2024. This sale does not represent a discretionary trade by the reporting person. For further information regarding the RSUs vested on April 9, 2024, refer to footnotes 2 and 3 of the reporting person's Form 4 filed with the SEC on April 11, 2024. For further information regarding the RSUs vested on April 11, 2024, refer to footnote 2 of the reporting person's Form 4 filed with the SEC on April 12, 2024.
- Represents a weighted average sales price per share. These shares were sold at prices ranging from $7.26 to $7.40. The reporting person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.